Judith M. Matthews
2017
In 2017, Judith M. Matthews earned a total compensation of $318.1K as Chief Financial Officer at Iterum Therapeutics plc.
Compensation breakdown
| Non-Equity Incentive Plan | $59,063 |
|---|---|
| Option Awards | $22,038 |
| Salary | $236,250 |
| Other | $788 |
| Total | $318,139 |
Matthews received $236.3K in salary, accounting for 74% of the total pay in 2017.
Matthews also received $59.1K in non-equity incentive plan, $22K in option awards and $788 in other compensation.
Rankings
In 2017, Judith M. Matthews' compensation ranked 13,192nd out of 14,666 executives tracked by ExecPay. In other words, Matthews earned more than 10.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,192 out of 14,666 | 10th |
Division Manufacturing | 5,193 out of 5,772 | 10th |
Major group Chemicals And Allied Products | 1,884 out of 2,075 | 9th |
Industry group Drugs | 1,571 out of 1,731 | 9th |
Industry Pharmaceutical Preparations | 1,215 out of 1,333 | 9th |
Source: SEC filing on April 25, 2019.
Matthews' colleagues
We found two more compensation records of executives who worked with Judith M. Matthews at Iterum Therapeutics plc in 2017.